{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-209172","form_type":"8-K","ticker":"QNCX","cik":"0001662774","company_name":"Quince Therapeutics, Inc.","filed_at":"2023-08-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.769779+00:00","generated_at":"2026-06-11T17:58:11.494543+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Quince Therapeutics CMO Karen Smith to depart effective Sept 1, 2023","bullets":["Chief Medical Officer Karen Smith, M.D., Ph.D. will depart on September 1, 2023.","Separation agreement includes 12 months base salary severance plus prorated 2023 bonus and health benefits lump sum.","Outstanding equity awards subject to 50% accelerated vesting; additional benefits if change in control occurs within 3 months after departure.","Dr. Smith will continue as employee until the departure date under transition and separation agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-209172","json":"https://secwatch.observer/filing/0001193125-23-209172.json","markdown":"https://secwatch.observer/filing/0001193125-23-209172.md","text":"https://secwatch.observer/filing/0001193125-23-209172.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1662774/000119312523209172/0001193125-23-209172-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1662774/000119312523209172/d538151d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T17:58:11.494543+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cd87fb8490","claim":"Karen Smith departed as Chief Medical Officer at Quince Therapeutics, Inc..","evidence_excerpt":"On July 24, 2023, Quince Therapeutics, Inc. (the “Company”) announced the departure of Karen Smith, M.D., Ph.D., the Company’s Chief Medical Officer, effective as of September 1, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1662774/000119312523209172/0001193125-23-209172-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"departure"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}